Tag archive for ‘gastric cancer’
Ambrx’s ARX788 gets FDA orphan drug status for gastric cancer treatment
By businessnewstoday On Saturday, April 24th, 2021
0 Comments

Ambrx’s ARX788 gets FDA orphan drug status for gastric cancer treatment

(adsbygoogle = window.adsbygoogle || []).push({}); Ambrx has announced that its antibody drug conjugate (ADC) ARX788 has been granted orphan drug designation by the US Food and Drug Administration More...

Amgen acquisition of Five Prime Therapeutics
By businessnewstoday On Thursday, March 4th, 2021
0 Comments

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add a phase 3 ready gastric cancer candidate called More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, June 12th, 2020
0 Comments

Leap Therapeutics gets FDA orphan status for DKN-01 for gastric and gastroesophageal junction cancer

US immuno-oncology company Leap Therapeutics has been granted orphan drug designation for DKN-01 from the US Food and Drug Administration (FDA) for the treatment of gastric and gastroesophageal junction cancer. DKN-01, More...

By pharmanewsdaily On Tuesday, January 29th, 2019
0 Comments

Everything you need to know about warning signs of stomach cancer

It is good to know about the warning signs of stomach cancer as the stomach cancer may go undetected for years. Stomach cancer is also known as gastric cancer and it affects the lining of the stomach before it spreads More...

By pharmanewsdaily On Monday, December 11th, 2017
0 Comments

Lilly’s ramucirumab fails to crack phase 3 gastric cancer trial

Eli Lilly and Company, which is better known as Lilly, says that a late-stage trial of Cyramza (ramucirumab) for the treatment of a form of gastric cancer met its primary goal of stopping the disease from advancing, More...